Iodine-131 derlotuximab biotin is a radiopharmaceutical that combines a targeted antibody with a radioactive isotope of iodine. The "131" in iodine-131 refers to its atomic mass, and it is commonly used in medical applications for its radioactive properties.
The Institute of Nuclear Medicine & Allied Sciences (INMAS) is a research and educational institution in India that focuses on the field of nuclear medicine and its applications in healthcare, particularly in diagnosis and therapy. It is associated with the Defence Research and Development Organisation (DRDO) and is often involved in research related to the use of nuclear techniques in medical imaging, radiation therapy, and other health-related applications.
Indium (111In) satumomab pendetide is a radiopharmaceutical used primarily in the imaging of certain types of cancer, particularly those related to the detection of colorectal cancer. Here's a breakdown of its components: - **Indium-111 (111In)**: A radioactive isotope of indium, which is used in a variety of diagnostic imaging procedures due to its ability to emit gamma radiation.
Indium-111 (111In) imciromab is a radiolabeled monoclonal antibody used in nuclear medicine, specifically for imaging purposes. Imciromab is a humanized monoclonal antibody that targets the CD20 antigen, which is commonly expressed on the surface of B-cell lymphocytes, including malignant B-cells found in certain types of lymphomas and leukemias.
Indium (111In) capromab pendetide is a radiopharmaceutical used primarily in the medical imaging and diagnosis of prostate cancer. It is a monoclonal antibody that targets prostate-specific membrane antigen (PSMA), which is often overexpressed in prostate cancer cells.
Indium (111In) altumomab pentetate, commonly referred to as Indium-111-penetreotide or by its brand names such as OctreoScan, is a radiopharmaceutical used for medical imaging, particularly in the detection of neuroendocrine tumors. ### Key Components: - **Indium-111**: This is a radioactive isotope of indium used as a tracer in nuclear medicine. It emits gamma rays, which can be detected by imaging devices.
Immunoscintigraphy is a medical imaging technique that utilizes radiolabeled antibodies or antibody fragments to visualize specific tissues or tumors within the body. It combines the principles of immunology and scintigraphy, which is a form of nuclear medicine imaging. In immunoscintigraphy, the antibodies used are typically designed to target specific antigens that are uniquely expressed or overexpressed on the surface of certain cancer cells or other tissues of interest.
The Imaging and Radiation Oncology Core (IROC) typically refers to a collaborative research and support infrastructure focused on advancing the fields of imaging and radiation oncology. It is often associated with clinical trials and research initiatives aimed at improving the effectiveness and safety of radiation therapy treatments for cancer patients. IROC facilities usually provide: 1. **Quality Assurance**: Ensuring that imaging and radiation delivery systems are functioning properly and delivering the expected doses to the targeted areas with minimal effects on surrounding healthy tissue.
The Gordon Center for Medical Imaging is an institution dedicated to advancing the field of medical imaging through research, education, and technology development. Located at the Massachusetts General Hospital (MGH) and affiliated with Harvard Medical School, the center focuses on various aspects of imaging technologies, including their application in diagnosing and treating medical conditions. The center often engages in projects related to the development of new imaging techniques, enhancing existing technologies, and improving patient care through innovative research.
Fallypride is a radiolabeled compound used in positron emission tomography (PET) imaging to study the dopamine D2 receptor in the brain. Its complete nomenclature is [(18)F]fallypride, which means it is labeled with the radioactive isotope fluorine-18.
Emission computed tomography (ECT) is a type of imaging technique used in medical diagnostics to visualize the distribution of radioactive materials in the body. It works by detecting the gamma rays emitted from a radiotracer that has been administered to the patient. There are two main types of ECT: Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT).
A dose profile typically refers to the distribution of a certain quantity (such as radiation, medication, or other substances) across a specific area, volume, or population over time. The term can apply in various fields, including: 1. **Medicine and Pharmacology**: In this context, a dose profile represents how a drug is administered to a patient over time, detailing factors like the amount of the drug given, the timing of doses, and the resulting plasma concentration levels in the body.
Desmethoxyfallypride, often abbreviated as DMFP, is a chemical compound that is classified as a research chemical. It is a derivative of fallypride, which is an antipsychotic drug that primarily acts as a dopamine receptor antagonist. DMFP has been investigated for its potential effects on the dopamine system and may be studied in the context of neuropharmacology.
The Committee on the Biological Effects of Ionizing Radiation (BEIR) is a group that operates under the National Academy of Sciences in the United States. Established to assess and report on the biological effects of ionizing radiation, the committee primarily focuses on the health risks associated with exposure to various types of ionizing radiation, including gamma rays, X-rays, and particle radiation.
Cardiac PET (Positron Emission Tomography) is a type of imaging technique that provides detailed information about the functioning of the heart. It uses positron-emitting radiotracers, which are generally injected into the bloodstream, to visualize and assess various cardiac parameters.
Bone-seeking radioisotopes are radioactive isotopes that have an affinity for bone tissue, allowing them to accumulate in areas of bone, particularly those that are undergoing changes such as growth, repair, or disease processes. These isotopes are commonly used in medical applications, particularly in the treatment and diagnosis of certain conditions.
The American Board of Science in Nuclear Medicine (ABSNM) is a professional organization that focuses on certifying individuals in the field of nuclear medicine. Established to promote the highest standards of practice in nuclear medicine, the ABSNM offers credentialing for professionals who meet specific educational and experience requirements. Certification by the ABSNM indicates that an individual has demonstrated a certain level of expertise and knowledge in nuclear medicine, which can include areas such as diagnostic imaging, radiation safety, and therapeutic procedures.
90Y-DOTA-biotin is a radiopharmaceutical compound that combines the radioactive isotope Yttrium-90 (90Y) with a chelating agent known as DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) and biotin.
VistA Imaging is a component of the Veterans Health Information Systems and Technology Architecture (VistA), which is the electronic health record system used by the U.S. Department of Veterans Affairs (VA). VistA Imaging specifically focuses on the management, storage, and retrieval of medical images and related data.
Therac-25 is a computer-controlled radiation therapy machine that was developed in the 1980s. It was designed to deliver high doses of radiation to patients with cancer, but it became infamously known due to a series of incidents that resulted in severe radiation overdoses to patients, leading to injuries and deaths. The machine was notable for its use of software to control its operations, which was relatively new for medical devices at the time.